Cargando…

In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients

The goal of the study was to determine the relationship between in vitro/in vivo efficacy of environmental Pseudomonas phages and certain phenotypical properties of Pseudomonas aeruginosa (PA) strains. We studied the diversity between particular isolates and determined phage sensitivity in vitro and...

Descripción completa

Detalles Bibliográficos
Autores principales: Olszak, Tomasz, Zarnowiec, Paulina, Kaca, Wieslaw, Danis-Wlodarczyk, Katarzyna, Augustyniak, Daria, Drevinek, Pavel, de Soyza, Anthony, McClean, Siobhán, Drulis-Kawa, Zuzanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480334/
https://www.ncbi.nlm.nih.gov/pubmed/25758956
http://dx.doi.org/10.1007/s00253-015-6492-6
_version_ 1782378145026932736
author Olszak, Tomasz
Zarnowiec, Paulina
Kaca, Wieslaw
Danis-Wlodarczyk, Katarzyna
Augustyniak, Daria
Drevinek, Pavel
de Soyza, Anthony
McClean, Siobhán
Drulis-Kawa, Zuzanna
author_facet Olszak, Tomasz
Zarnowiec, Paulina
Kaca, Wieslaw
Danis-Wlodarczyk, Katarzyna
Augustyniak, Daria
Drevinek, Pavel
de Soyza, Anthony
McClean, Siobhán
Drulis-Kawa, Zuzanna
author_sort Olszak, Tomasz
collection PubMed
description The goal of the study was to determine the relationship between in vitro/in vivo efficacy of environmental Pseudomonas phages and certain phenotypical properties of Pseudomonas aeruginosa (PA) strains. We studied the diversity between particular isolates and determined phage sensitivity in vitro and in vivo in the Galleria mellonella insect model. Twenty-eight lytic bacteriophages specific for PA were tested against 121 CF PA isolates including 29 mucoid PA strains. Most strains from cystic fibrosis (CF) patients were lysed by at least three phages (93.6 %), but completely insensitive strains were also present (6.4 %). Two phages PA5oct and KT28 exhibited high rates of lytic potency on 55–68 % of PA strains (72–86 % of mucoid isolates). We further explored phage activity against six PA strains (CF and non-CF) in vitro, comparing clonal differences in phage susceptibility with bacterial properties such as the ability to form biofilms, mucosity, twitching motility, and biochemical profiles. We observed the relationship between variation in phage susceptibility and Fourier transform infrared spectroscopy (FTIR) analysis in the spectra window of carbohydrates. The protective efficacy of two selected phages against PA PAO1 and 0038 infection was confirmed in vivo in G. mellonella larvae. Generally, the wax moth model results confirmed the data from in vitro assays, but in massive infection of CF isolates, the application of lytic phages probably led to the release of toxic compound causing an increase in larvae mortality. We assumed that apart of in vitro phage activity testing, a simple and convenient wax moth larvae model should be applied for the evaluation of in vivo effectiveness of particular phage preparations.
format Online
Article
Text
id pubmed-4480334
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-44803342015-07-01 In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients Olszak, Tomasz Zarnowiec, Paulina Kaca, Wieslaw Danis-Wlodarczyk, Katarzyna Augustyniak, Daria Drevinek, Pavel de Soyza, Anthony McClean, Siobhán Drulis-Kawa, Zuzanna Appl Microbiol Biotechnol Applied Microbial and Cell Physiology The goal of the study was to determine the relationship between in vitro/in vivo efficacy of environmental Pseudomonas phages and certain phenotypical properties of Pseudomonas aeruginosa (PA) strains. We studied the diversity between particular isolates and determined phage sensitivity in vitro and in vivo in the Galleria mellonella insect model. Twenty-eight lytic bacteriophages specific for PA were tested against 121 CF PA isolates including 29 mucoid PA strains. Most strains from cystic fibrosis (CF) patients were lysed by at least three phages (93.6 %), but completely insensitive strains were also present (6.4 %). Two phages PA5oct and KT28 exhibited high rates of lytic potency on 55–68 % of PA strains (72–86 % of mucoid isolates). We further explored phage activity against six PA strains (CF and non-CF) in vitro, comparing clonal differences in phage susceptibility with bacterial properties such as the ability to form biofilms, mucosity, twitching motility, and biochemical profiles. We observed the relationship between variation in phage susceptibility and Fourier transform infrared spectroscopy (FTIR) analysis in the spectra window of carbohydrates. The protective efficacy of two selected phages against PA PAO1 and 0038 infection was confirmed in vivo in G. mellonella larvae. Generally, the wax moth model results confirmed the data from in vitro assays, but in massive infection of CF isolates, the application of lytic phages probably led to the release of toxic compound causing an increase in larvae mortality. We assumed that apart of in vitro phage activity testing, a simple and convenient wax moth larvae model should be applied for the evaluation of in vivo effectiveness of particular phage preparations. Springer Berlin Heidelberg 2015-03-12 2015 /pmc/articles/PMC4480334/ /pubmed/25758956 http://dx.doi.org/10.1007/s00253-015-6492-6 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Applied Microbial and Cell Physiology
Olszak, Tomasz
Zarnowiec, Paulina
Kaca, Wieslaw
Danis-Wlodarczyk, Katarzyna
Augustyniak, Daria
Drevinek, Pavel
de Soyza, Anthony
McClean, Siobhán
Drulis-Kawa, Zuzanna
In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
title In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
title_full In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
title_fullStr In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
title_full_unstemmed In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
title_short In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
title_sort in vitro and in vivo antibacterial activity of environmental bacteriophages against pseudomonas aeruginosa strains from cystic fibrosis patients
topic Applied Microbial and Cell Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480334/
https://www.ncbi.nlm.nih.gov/pubmed/25758956
http://dx.doi.org/10.1007/s00253-015-6492-6
work_keys_str_mv AT olszaktomasz invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients
AT zarnowiecpaulina invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients
AT kacawieslaw invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients
AT daniswlodarczykkatarzyna invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients
AT augustyniakdaria invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients
AT drevinekpavel invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients
AT desoyzaanthony invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients
AT mccleansiobhan invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients
AT druliskawazuzanna invitroandinvivoantibacterialactivityofenvironmentalbacteriophagesagainstpseudomonasaeruginosastrainsfromcysticfibrosispatients